Methodology Study To Assess The Ability Of A Randomized, Double-Blind, Placebo-Controlled, Two Period Crossover Study To Detect The Efficacy Of Pregabalin In Post-Traumatic Neuropathic Pain Patients.
Phase of Trial: Phase I
Latest Information Update: 26 Feb 2010
At a glance
- Drugs Pregabalin (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- Sponsors Pfizer
- 02 Mar 2009 Actual patient numbers (25) added as reported by ClinicalTrials.gov.
- 02 Mar 2009 Actual end date (Feb 2009) added as reported by ClinicalTrials.gov.
- 02 Mar 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.